Mercy Research Celebrates Ten Years of Impactful Clinical Trials and Patient Care

A Decade of Innovation and Caring: Mercy Research Milestone



As Mercy Research proudly reports a decade of impactful advancements, this year marks a significant milestone for an organization that has dedicated its efforts to enhancing patient care through clinical trials.

Established with the core mission of advancing healthcare by providing access to clinical research, Mercy Research has grown into a nationally recognized program, offering patients over 300 clinical trials across various medical specialties, including oncology, cardiovascular health, neuroscience, and infectious diseases. This comprehensive approach allows eligible participants to access groundbreaking therapies and innovative treatment options much earlier than they would in standard medical practice.

For many patients, engaging in clinical trials means not only gaining access to innovative treatment options but also participating in research that will ultimately shape future medical practices. Mercy Research aims to keep patients in their communities, minimizing the need to travel long distances to participate in these vital studies. JoAnne Levy, the vice president of Mercy Research, emphasizes the importance of community-based trials, as they allow patients to receive care closer to home without the burden of travel expenses.

Take, for instance, the story of Deborah Cottle, who after battling pancreatic cancer, was able to receive an investigational drug through the FDA's expanded access program at Mercy. Instead of enduring long journeys to larger academic medical centers, she found comfort in staying within her community, which allowed her to cherish more moments with her family during her treatment.

Over the last ten years, Mercy Research's contribution extends beyond providing trial access; the organization plays a pivotal role in advancing medical science. Achievements include advancements in early cancer detection methods, introduction of novel treatments for heart failure, utilization of proton beam therapy, and enhancing methods for sepsis identification.

As Mercy Research looks toward the future, it aims to continue expanding patient access to clinical trials while exploring initiatives in precision medicine and artificial intelligence-enabled research. These efforts reflect Mercy’s ongoing commitment to ensuring patients receive state-of-the-art healthcare without the barriers typically found in clinical research participation.

Mercy stands as one of the 15 largest healthcare systems in the United States, well-regarded for its high-quality patient experience, as recognized by NRC Health. The system serves millions of patients annually and has evolved into a highly integrated, multi-state healthcare entity encompassing 55 acute care and specialty hospitals, outpatient facilities, urgent care locations, imaging centers, and pharmacies across five states: Arkansas, Illinois, Kansas, Missouri, and Oklahoma.

In just fiscal year 2025, Mercy provided over half a billion dollars in free care and other community benefits, showcasing its commitment to accessible healthcare for the communities it serves. With a dedicated workforce of more than 50,000 caregivers and 1,000 physician practice locations, Mercy understands that patient-focused care is paramount.

As Mercy Research embarks on this new chapter, its advancements and commitment to accessibility will undoubtedly lead to transformative experiences not only for patients but also for the broader medical community, paving the way for innovations in healthcare delivery and treatment methodologies.

Topics Health)

【About Using Articles】

You can freely use the title and article content by linking to the page where the article is posted.
※ Images cannot be used.

【About Links】

Links are free to use.